Impact of price deregulation policy on the affordability of essential medicines for women's health: a panel data analysis
{{output}}
Background: A new policy which required deregulation on prices of off-patent medicines for women's health during procurement was introduced in China in September 2015. The current study examines this policy's impact on the afford... ...
